Advertisement

Topics

Tanezumab's Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments

04:11 EDT 6 Sep 2018 | Forbes

As the opioid crisis has unfolded concerns have grown about dependency and the potentially addictive nature of opioid-based pain treatments. Having satisfactory non-opioid treatment alternatives will need to be an integral part of effective pain management.

Original Article: Tanezumab's Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments

NEXT ARTICLE

More From BioPortfolio on "Tanezumab's Phase 3 Results: A Promising Sign For Non-Opioid Pain Treatments"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...